Skip to main content
Article thumbnail
Location of Repository

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)

By Baiba Hedegaard Hansen, Jamal Abed Hanash, Alice Rasmussen, Jørgen Fischer Hansen and Morten Birket-Smith
Topics: Study Protocol
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2674039
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1960). A rating scale for depression.
    2. (2002). A: Betathromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatry Res
    3. (2000). A: Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine.
    4. (2006). Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.
    5. (2004). Akut koronart syndrom. Retningslinjer for diagnostik og behandling. København, Dansk Cardiologisk Selskab;
    6. (1961). An inventory for measuring depression. Arch Gen Psychiatry
    7. (2000). AS: Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med
    8. (1999). Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ
    9. (2001). CM: Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res
    10. (2004). CR: Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf
    11. (2007). CREATE Investigators: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA
    12. (2006). Creed FH: Contribution of depression and anxiety to impaired health-related quality of life following first myocardial infarction.
    13. (2005). DE: Effect of depression on five-year mortality after an acute coronary syndrome.
    14. (1995). Depression and 18-month prognosis after myocardial infarction. Circulation
    15. (2005). Depression following myocardial infarction: firstever versus ongoing and recurrent episodes. Gen Hosp Psychiatry
    16. (2001). Depression, heart rate variability, and acute myocardial infarction. Circulation
    17. (2005). Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther
    18. (2006). Domburg RT: Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention.
    19. (2007). Dunner DL: Preventing recurrent depression: long-term treatment for major depressive disorder.
    20. (2006). E: Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey. BMC Health Serv Res
    21. ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338.
    22. (2001). Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J
    23. (2004). Egberts AC: Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med
    24. (2000). Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators. Am Heart J
    25. (2005). Erickson SR: Depressive symptoms and treatment after acute coronary syndrome.
    26. (2002). Frenneaux MP: Arterial endothelial function is impaired in treated depression. Heart
    27. (2001). Gurbel PA: Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease.
    28. (2006). Heldbo RE: Escitalopram in the long-term treatment of major depressive disorder. Ann Clin Psychiatry
    29. (2003). Honig A: Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction.
    30. (2006). Honig A: Recognizing increased risk of depressive comorbidity after myocardial infarction: looking for 4 symptoms of anxiety-depression. Psychother Psychosom
    31. (2006). IB: Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry
    32. (2005). Impaired endothelial function in coronary heart disease patients with depressive symptomatology.
    33. (1995). Jaffe AS: Association of depression with reduced heart rate variability in coronary artery disease.
    34. (2005). Jaffe AS: Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med
    35. (1999). Jaffe AS: Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry
    36. (1994). JG: Utility of a new procedure for diagnosing mental disorders in primary care.
    37. (2000). JP: Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
    38. (2005). Keam SJ: Escitalopram: a review of its use in the management of major depressive disorder. Drugs
    39. (2000). LC: Platelet activation in depression and effects of sertraline treatment: An open-label study.
    40. (2000). MG: Depression and health-care costs during the first year following myocardial infarction.
    41. (2005). MIM: Serotonin Reuptake Inhibitors and Cardiovascular Disease. Vascular Disease Prevention
    42. (2007). MIND-IT investigators: Effects of antidepressant treatment following myocardial infarction.
    43. (2005). MIND-IT investigators: Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J
    44. (2006). MP: Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther
    45. (1997). MS: Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry
    46. (2005). Nemeroff C: Effects of paroxetine and venlafaxine XR on heart rate variability in depression.
    47. (2003). P: A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics
    48. (2000). Praag HM: Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med
    49. (2006). PREMIER Registry Investigators: Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women.
    50. (2005). Psychosocial predictors of depression in patients with acute coronary syndrome. Acta Psychiatr Scand
    51. (1993). Scales of Assessment of Diagnosis and Severity of Mental Disorders. Acta Psychiatr Scand Suppl
    52. Schedules for Clinical Assessment in Neuropsychiatry, Version 2.1.
    53. (2003). SE: Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation
    54. (2002). Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA
    55. (2006). Spertus JA: The prevalence of unrecognized depression in patients with acute coronary syndrome. Am Heart J
    56. (1996). Talajic M: Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med
    57. (1995). Talajic M: The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol
    58. (1959). The assessment of anxiety states by rating.
    59. (2004). The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost
    60. (2004). The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand
    61. (1987). The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl
    62. (2007). Thombs BD: Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes.
    63. (2003). Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a populationbased cohort study. Arch Intern Med
    64. (2005). Ziegelstein RC: Depression following acute myocardial infarction: a prospective relationship with ongoing health and function. Psychosomatics
    65. (2008). Ziegelstein RC: Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.